1. Home
  2. FOA vs MBX Comparison

FOA vs MBX Comparison

Compare FOA & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOA
  • MBX
  • Stock Information
  • Founded
  • FOA 2013
  • MBX 2018
  • Country
  • FOA United States
  • MBX United States
  • Employees
  • FOA N/A
  • MBX N/A
  • Industry
  • FOA Finance Companies
  • MBX
  • Sector
  • FOA Finance
  • MBX
  • Exchange
  • FOA Nasdaq
  • MBX NYSE
  • Market Cap
  • FOA 247.0M
  • MBX 300.5M
  • IPO Year
  • FOA N/A
  • MBX 2024
  • Fundamental
  • Price
  • FOA $21.21
  • MBX $13.14
  • Analyst Decision
  • FOA Buy
  • MBX Strong Buy
  • Analyst Count
  • FOA 2
  • MBX 5
  • Target Price
  • FOA $26.25
  • MBX $37.40
  • AVG Volume (30 Days)
  • FOA 85.2K
  • MBX 255.6K
  • Earning Date
  • FOA 05-06-2025
  • MBX 05-12-2025
  • Dividend Yield
  • FOA N/A
  • MBX N/A
  • EPS Growth
  • FOA N/A
  • MBX N/A
  • EPS
  • FOA 3.94
  • MBX N/A
  • Revenue
  • FOA $429,184,000.00
  • MBX N/A
  • Revenue This Year
  • FOA $15.98
  • MBX N/A
  • Revenue Next Year
  • FOA $9.04
  • MBX N/A
  • P/E Ratio
  • FOA $5.34
  • MBX N/A
  • Revenue Growth
  • FOA 155.35
  • MBX N/A
  • 52 Week Low
  • FOA $4.10
  • MBX $4.81
  • 52 Week High
  • FOA $32.40
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • FOA 49.32
  • MBX N/A
  • Support Level
  • FOA $20.50
  • MBX N/A
  • Resistance Level
  • FOA $22.40
  • MBX N/A
  • Average True Range (ATR)
  • FOA 1.05
  • MBX 0.00
  • MACD
  • FOA -0.03
  • MBX 0.00
  • Stochastic Oscillator
  • FOA 26.79
  • MBX 0.00

About FOA Finance of America Companies Inc.

Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: